Fluorescence-guided optical coherence tomography imaging for colon cancer screening: A preliminary mouse study

Biomedical Optics Express

Volumn 3, Issue 1, 2012, Pages 178-191

  Iftimia, Nicusor ^a   Iyer, Arun K ^b   Hammer, Daniel X ^a   Lue, Niyom ^a   Mujat, Mircea ^a   Pitman, Martha ^c   Daniel Ferguson, R ^a   Amiji, Mansoor ^b  

^a PHYSICAL SCIENCES INC   (United States)

^b NORTHEASTERN UNIVERSITY   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; DISEASES; FLUORESCENCE; INFRARED DEVICES; MAMMALS; MORPHOLOGY; TISSUE;

ABNORMAL TISSUES; ARGENINE-GLYCINE-ASPARTIC ACIDS; CANCER SCREENING; CANCER-TARGETING; COLON CANCER; CONTRAST AGENT; EPITHELIAL CANCER CELLS; FUNCTIONALIZED; HIGH RESOLUTION; IN-VIVO; INTEGRIN RECEPTORS; LASER-INDUCED FLUORESCENCE IMAGING; MICRO-PARTICLES; MICRON SCALE; NEAR INFRA RED; OCT IMAGING; PILOT STUDIES; POLY(EPSILON-CAPROLACTONE); TISSUE MORPHOLOGY;

OPTICAL TOMOGRAPHY;

ANIMALIA; MUS;

EID: 84863950923     PISSN: None     EISSN: 21567085     Source Type: Journal    
DOI: 10.1364/BOE.3.000178     Document Type: Article

References (37)

1. H. Tajiri, A. Ohtsu, N. Boku, M. Muto, K. Chin, S. Matsumoto, and S. Yoshida. "Routine endoscopy using electronic endoscopes for gastric cancer diagnosis: retrospective study of inconsistencies between endoscopic and biopsy diagnoses," Cancer Detect. Prev. 25(2), 166-173 (2001).
2. G. Jeffery, B. Hickey, and P. N. Hilder, "Follow up strategies for patients treated for non-metastatic colorectal cancer (Review)," Cochrane Database Syst. Rev. 1, 1-27 (2008), http://generalsurgery.utoronto.ca/Assets/GenSurgery+Digital+Assets/Hospitals/cochranereview.pdf.
3. O. Hosokawa, K. Watanabe, M. Hatorri, K. Douden, H. Hayashi, and Y. Kaizaki, "Detection of gastric cancer by repeat endoscopy within a short time after negative examination," Endoscopy 33(4), 301-305 (2001).
4. R. Lambert and J. F. Rey, "Endoscopy and early neoplasia: better but not the best," Endoscopy 33(4), 348-352 (2001).
5. J. J. Ott, A. Ullrich, and A. B. Miller, "The importance of early symptom recognition in the context of early detection and cancer survival," Eur. J. Cancer 45(16), 2743-2748 (2009).
6. E. D. A. Westcott and A. C. J. Windsor, "Can we improve the outcome of colorectal cancer by early diagnosis?" Postgrad. Med. J. 78(919), 255-256 (2002).
7. W. A. Weber, J. Czernin, M. E. Phelps, and H. R. Herschman, "Technology Insight: novel imaging of molecular targets is an emerging area crucial to the development of targeted drugs," Nat. Clin. Pract. Oncol. 5(1), 44-54 (2008).
8. T. F. Massoud and S. S. Gambhir, "Integrating noninvasive molecular imaging into molecular medicine: an evolving paradigm," Trends Mol. Med. 13(5), 183-191 (2007).
9. N. K. Tafreshi, V. Kumar, D. L. Morse, and R. A. Gatenby, "Molecular and functional imaging of breast cancer," Cancer Contr. 17(3), 143-155 (2010).
10. K. Brindle, "New approaches for imaging tumour responses to treatment," Nat. Rev. Cancer 8(2), 94-107 (2008).
11. M. A. Rosen and M. D. Schnall, "Dynamic contrast-enhanced magnetic resonance imaging for assessing tumor vascularity and vascular effects of targeted therapies in renal cell carcinoma," Clin. Cancer Res. 13(2), 770s-776s (2007).
12. M. C. Pierce, D. J. Javier, and R. Richards-Kortum, "Optical contrast agents and imaging systems for detection and diagnosis of cancer," Int. J. Cancer 123(9), 1979-1990 (2008).
13. M. V. Sivak Jr., K. Kobayashi, J. A. Izatt, A. M. Rollins, R. Ung-Runyawee, A. Chak, R. C. Wong, G. A. Isenberg, and J. Willis, "High-resolution endoscopic imaging of the GI tract using optical coherence tomography," Gastrointest. Endosc. 51(4), 474-479 (2000).
14. R. A. Drezek, T. Collier, C. K. Brookner, A. Malpica, R. Lotan, R. R. Richards-Kortum, and M. Follen, "Laser scanning confocal microscopy of cervical tissue before and after application of acetic acid," Am. J. Obstet. Gynecol. 182(5), 1135-1139 (2000).
15. L. P. Hariri, G. T. Bonnema, K. Schmidt, A. M. Winkler, V. Korde, K. D. Hatch, J. R. Davis, M. A. Brewer, and J. K. Barton, "Laparoscopic optical coherence tomography imaging of human ovarian cancer," Gynecol. Oncol. 114(2), 188-194 (2009).
16. M. Kraft, H. Glanz, S. von Gerlach, H. Wisweh, H. Lubatschowski, and C. Arens, "Clinical value of optical coherence tomography in laryngology," Head Neck 30(12), 1628-1635 (2008).
17. J. A. Evans, B. E. Bouma, J. Bressner, M. Shishkov, G. Y. Lauwers, M. Mino-Kenudson, N. S. Nishioka, and G. J. Tearney, "Identifying intestinal metaplasia at the squamocolumnar junction by using optical coherence tomography," Gastrointest. Endosc. 65(1), 50-56 (2007).
18. B. E. Bouma, G. J. Tearney, C. C. Compton, and N. S. Nishioka, "High-resolution imaging of the human esophagus and stomach in vivo using optical coherence tomography," Gastrointest. Endosc. 51(4), 467-474 (2000).
19. P. A. Testoni, A. Mariani, B. Mangiavillano, P. G. Arcidiacono, S. di Pietro, and E. Masci, "Intraductal optical coherence tomography for investigating main pancreatic duct strictures," Am. J. Gastroenterol. 102(2), 269-274 (2007).
20. N. Iftimia, S. Cizginer, V. Deshpande, M. Pitman, S. Tatli, N. A. Iftimia, D. X. Hammer, M. Mujat, T. Ustun, R. D. Ferguson, and W. R. Brugge, "Differentiation of pancreatic cysts with optical coherence tomography (OCT) imaging: an ex vivo pilot study," Biomed. Opt. Express 2(8), 2372-2382 (2011).
21. J. Ai, E. Biazar, M. Jafarpour, M. Montazeri, A. Majdi, S. Aminifard, M. Zafari, H. R. Akbari, and H. G. Rad, "Nanotoxicology and nanoparticle safety in biomedical designs," Int. J. Nanomedicine 6, 1117-1127 (2011).
22. N. Lue, S. Ganta, D. X. Hammer, M. Mujat, A. E. Stevens, L. Harrison, R. D. Ferguson, D. Rosen, M. Amiji, and N. Iftimia, "Preliminary evaluation of a nanotechnology-based approach for the more effective diagnosis of colon cancers," Nanomedicine (Lond.) 5(9), 1467-1479 (2010).
23. G.-Y. Yang, K.-S. Xu, Z.-Q. Pan, Z.-Y. Zhang, Y.-T. Mi, J.-S. Wang, R. Chen, and J. Niu, "Integrin alphavbeta6 mediates the potential for colon cancer cells to colonize in and metastasize to the liver," Cancer Sci. 99(5), 879-887 (2008).
24. R. Del Buono, M. Pignatelli, W. F. Bodmer, and N. A. Wright, "The role of the arginine-glycine-aspartic acid-directed cellular binding to type I collagen and rat mesenchymal cells in colorectal tumour differentiation," Differentiation 46(2), 97-103 (1991).
25. D. Meyer, G. Nickols, J. Pegg, and W. Westlin, "An oral alpha-v-beta-3 antagonist, S-247, induces tumor regression and inhibits hypercalcemia of malignancy in a syngeneic mouse colon model," Proc. Am. Assoc. Cancer Res. 42, 825 (2001).
26. D. Griggs, K. Shannon, S. Settle, T. Duffin, M. Nickols, S. Schroeter, N. Gickols, and W. Westlin, "Anti-metastatic efficacy mediated by peptidomimetic alpha-v-beta-3 integrin antagonists in orthotopic and experimental models," Proc. Am. Assoc. Cancer Res. 42, 263 (2001).
27. T. E. Ustun, N. V. Iftimia, R. D. Ferguson, and D. X. Hammer, "Real-time processing for Fourier domain optical coherence tomography using a field programmable gate array, Rev. Sci. Instrum. 79(11), 114301 (2008).
28. H. L. Kettunen, A. S. L. Kettunen, and N. E. Rautonen, "Intestinal immune responses in wild-type and Apcmin/+ mouse, a model for colon cancer," Cancer Res. 63(16), 5136-5142 (2003).
29. N. Howlader, A. M. Noone, M. Krapcho, N. Neyman, R. Aminou, W. Waldron, S. F. Altekruse, C. L. Kosary, J. Ruhl, Z. Tatalovich, H. Cho, A. Mariotto, M. P. Eisner, D. R. Lewis, H. S. Chen, E. J. Feuer, K. A. Cronin, and B. K. Edwards, eds., Surveillance Epidemiology and End Results, Cancer Statistics Review, 1975-2008, National Cancer Institute, Bethesda MD, http://seer.cancer.gov/csr/1975-2008.
30. M. S. Cappell, "Pathophysiology, clinical presentation, and management of colon cancer," Gastroenterol. Clin. North Am. 37(1), 1-24, v (2008).
31. C. E. Desch, A. B. Benson 3rd, M. R. Somerfield, P. J. Flynn, C. Krause, C. L. Loprinzi, B. D. Minsky, D. G. Pfister, K. S. Virgo, and N. J. Petrelli, American Society of Clinical Oncology, "Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guideline," J. Clin. Oncol. 23(33), 8512-8519 (2005).
32. P. R. Pfau, M. V. Sivak Jr., A. Chak, M. Kinnard, R. C. Wong, G. A. Isenberg, J. A. Izatt, A. Rollins, and V. Westphal, "Criteria for the diagnosis of dysplasia by endoscopic optical coherence tomography," Gastrointest. Endosc. 58(2), 196-202 (2003).
33. A. R. Tumlinson, L. P. Hariri, U. Utzinger, and J. K. Barton, "Miniature endoscope for simultaneous optical coherence tomography and laser-induced fluorescence measurement," Appl. Opt. 43(1), 113-121 (2004).
34. S. Y. Ryu, H. Y. Choi, J. Na, E. S. Choi, and B. H. Lee, "Combined system of optical coherence tomography and fluorescence spectroscopy based on double-cladding fiber," Opt. Lett. 33(20), 2347-2349 (2008).
35. J. Park, J. A. Jo, S. Shrestha, P. Pande, Q. Wan, and B. E. Applegate, "A dual-modality optical coherence tomography and fluorescence lifetime imaging microscopy system for simultaneous morphological and biochemical tissue characterization," Biomed. Opt. Express 1(1), 186-200 (2010).
36. S. Yuan, C. A. Roney, J. Wierwille, C. W. Chen, B. Xu, G. Griffiths, J. Jiang, H. Ma, A. Cable, R. M. Summers, and Y. Chen, "Co-registered optical coherence tomography and fluorescence molecular imaging for simultaneous morphological and molecular imaging," Phys. Med. Biol. 55(1), 191-206 (2010).
37. C. A. Roney, B. Xu, J. Xie, S. Yuan, J. Wierwille, C. W. Chen, Y. Chen, G. L. Griffiths, and R. M. Summers, "Rh-I-UEA-1 polymerized liposomes target and image adenomatous polyps in the APC(Min/+) mouse using optical colonography," Mol. Imaging 10(4), 305-316 (2011).